Frequency and duration of Ursodeoxycholic acid 450mg tablets for increase bilirubin case and the value of increased bilirubin is 2.2 ?
Reading File
UDCA (Ursodeoxycholic acid) is used for liver/biliary conditions such as primary biliary cholangitis, intrahepatic cholestasis, and gallstone dissolution. For mildly elevated bilirubin (2.2 mg/dL), the typical dose is 13-15 mg/kg/day, divided into 2-3 doses. At 450 mg tablets, this usually means 1 tablet twice or three times daily depending on body weight and the underlying cause.
Searching sources...
Finding Sources
Searching the Web
ursodeoxycholic acid UDCA 450mg dosing frequency duration elevated bilirubin
Finding Sources
Here is a clear, evidence-based answer for UDCA 450 mg tablets in a case of mildly elevated bilirubin (2.2 mg/dL):
Ursodeoxycholic Acid (UDCA) 450 mg - Dosing for Elevated Bilirubin
Context - What Is Bilirubin 2.2 mg/dL?
A total bilirubin of 2.2 mg/dL is mildly elevated (normal: 0.2-1.2 mg/dL). This level suggests early/mild cholestatic liver disease, intrahepatic cholestasis, or conditions like Primary Biliary Cholangitis (PBC), intrahepatic cholestasis of pregnancy (ICP), or non-alcoholic fatty liver disease with cholestasis. UDCA is indicated when the cause is cholestatic in nature.
Standard UDCA Dosing (Evidence-Based)
The universally accepted dose is 13-15 mg/kg/day (EASL, AASLD, BSG guidelines; confirmed in Goldman-Cecil Medicine: "Ursodeoxycholic acid therapy (12 to 15 mg/kg/day) improves serum bilirubin, alkaline phosphatase, and cholesterol levels").
UDCA 450 mg Tablet - Frequency by Body Weight:
| Body Weight | Total Daily Dose (13-15 mg/kg) | 450 mg Tablets | Regimen |
|---|---|---|---|
| 50-60 kg | 650-900 mg/day | 1.5-2 tablets | 1 tablet twice daily (BD) |
| 60-70 kg | 780-1050 mg/day | 2 tablets | 1 tablet twice daily (BD) |
| 70-80 kg | 910-1200 mg/day | 2 tablets | 1 tablet twice daily (BD) |
| 80-90 kg | 1040-1350 mg/day | 3 tablets | 1 tablet three times daily (TDS) |
| >90 kg | >1170 mg/day | 3 tablets | 1 tablet three times daily (TDS) |
Most common prescription for average adult (60-80 kg): UDCA 450 mg - 1 tablet twice daily (BD)
Duration of Treatment
The duration depends on the underlying cause:
| Condition | Duration |
|---|---|
| Primary Biliary Cholangitis (PBC) | Lifelong - treatment should never be stopped even if bilirubin normalizes, as normalization means it is working |
| Intrahepatic Cholestasis of Pregnancy (ICP) | Until delivery (typically from diagnosis ~28-32 weeks until delivery), then reassess; usually stopped postpartum once labs normalize |
| Cholestatic hepatitis / NAFLD with cholestasis | 3-6 months minimum; continue if response seen, reassess periodically |
| Drug-induced cholestasis | Until the offending drug is removed and liver tests normalize (weeks to months) |
| Gallstone dissolution | 6-24 months until dissolution confirmed on ultrasound |
Key Points
- Take with food to improve absorption (preferably with the main meals or at bedtime)
- Monitor liver function tests (LFTs) including bilirubin at 1 month, then every 3-6 months
- A bilirubin of 2.2 mg/dL is mild - response to UDCA is typically good at this stage; expect improvement in bilirubin within 3-6 months of treatment
- If bilirubin does not improve after 3-6 months of adequate UDCA dosing, re-evaluate the diagnosis and consider adding second-line agents (obeticholic acid for PBC)
- In pregnancy-related cholestasis (ICP), the standard dose is slightly higher: 15-20 mg/kg/day
Typical prescription written:
Ursodeoxycholic Acid 450 mg - 1 tablet twice daily (BD) with meals - Duration: as per underlying diagnosis (minimum 3-6 months for cholestatic disease; lifelong for PBC)
Important note: The exact frequency and duration must be determined by the treating physician based on the patient's weight, underlying diagnosis, and treatment response. This is guidance only - not a substitute for clinical judgment.
This is a shared conversation. Sign in to Orris to start your own chat.